Skip to main content
. 2017 Jan 6;10(1):17–21. doi: 10.1136/neurintsurg-2016-012830

Table 1.

Baseline demographics, comorbidities and treatment times

EV-Only (n=52) IV+EV (n=38)
Age, mean (SD) 69 (18) 63 (19) 0.15
Female patients, n (%) 32 (61) 18 (47) 0.18
ICA-T, n (%)/MCA, n (%) 8 (15)/44 (85) 4 (10.5)/34 (89.5) 0.5
Diabetes, n (%) 15 (29) 7 (18) 0.25
Hypertension, n (%) 38 (73) 21 (55) 0.08
Hyperlipidemia, n (%) 27 (52) 17 (45) 0.5
Atrial fibrillation, n (%) 24 (46) 10 (26) 0.052
Smoking, n (%) 12 (23) 5 (13.) 0.23
NIHSS, median (IQR) 16 (10–22) 18 (13–23) 0.08
CT ASPECTS 7.5 (6–9) 8 (7–9) 0.09
Mean (SD) time from symptom onset, hour:min 5:19 (4:30) 1:46 (0:52) <0.0001*
Mean (SD) CT–INR, hour:min 0:47 (0:32) 1:00 (0:33) 0.054
Mean (SD) procedure duration, hour:min 1:11 (0:33) 1:16 (0:37) 0.47

*Significance level is set at 0.05.

EV-Only, endovascular therapy alone group; ICA-T, internal carotid artery terminus; IV+EV, endovascular therapy following IV rt-PA administration group; MCA, middle cerebral artery; NIHSS, NIH Stroke Scale.